reiterateNOCfinnhub
UBS Reiterates Buy Rating on Northrop Grumman Corporation (NOC)
UBS reiterated its Buy rating on Northrop Grumman Corporation (NYSE:NOC) on October 21, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
UBS reiterated its Buy rating on Northrop Grumman Corporation (NYSE:NOC) on October 21, 2026.
Read moreBNP Paribas reiterated its Outperform rating on Northrop Grumman Corporation (NYSE:NOC) on October 21, 2026.
Read moreMorgan Stanley reiterated its Overweight rating on Northrop Grumman Corporation (NYSE:NOC) on October 21, 2026.
Read moreJP Morgan reiterated its Neutral rating on Marriott International, Inc. (NASDAQ:MAR) on October 21, 2026.
Read moreJP Morgan reiterated its Neutral rating on Corning Incorporated (NYSE:GLW) on October 21, 2026.
Read moreBernstein reiterated its Outperform rating on United Parcel Service, Inc. (NYSE:UPS) on October 21, 2026.
Read moreGuggenheim analysts initiated coverage on Kazia Therapeutics Limited (NASDAQ:KZIA) with a rating of Buy on October 21, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Duos Technologies Group, Inc. (NASDAQ:DUOT) on October 21, 2026.
Read morePiper Sandler reiterated its Neutral rating on Home Bancorp, Inc. (NASDAQ:HBCP) on October 21, 2026.
Read morePiper Sandler reiterated its Overweight rating on Dime Community Bancshares, Inc. (NASDAQ:DCOM) on October 21, 2026.
Read moreSusquehanna reiterated its Neutral rating on Knowles Corporation (NYSE:KN) on October 21, 2026.
Read moreCitizens reiterated its Market Outperform rating on AtriCure, Inc. (NASDAQ:ATRC) on October 21, 2026.
Read moreSusquehanna reiterated its Positive rating on Power Integrations, Inc. (NASDAQ:POWI) on October 21, 2026.
Read moreTD Cowen reiterated its Buy rating on Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) on October 21, 2026.
Read moreMizuho reiterated its Neutral rating on Neptune Insurance Holdings Inc. (NYSE:NP) on October 21, 2026.
Read moreTruist Securities reiterated its Buy rating on Arcus Biosciences, Inc. (NYSE:RCUS) on October 21, 2026.
Read moreWedbush reiterated its Outperform rating on Arcus Biosciences, Inc. (NYSE:RCUS) on October 21, 2026.
Read moreBTIG analysts downgraded Braze, Inc. (NASDAQ:BRZE) from Buy to Neutral on October 21, 2026.
Read moreDA Davidson analysts downgraded Braze, Inc. (NASDAQ:BRZE) from Buy to Neutral on October 21, 2026.
Read moreRaymond James analysts downgraded Braze, Inc. (NASDAQ:BRZE) from Outperform to Market Perform on October 21, 2026.
Read more